USA flag logo/image

An Official Website of the United States Government

ANTIGENICITY OF GONOCOCCAL PILUS OLIGOMERS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
7090
Program Year/Program:
1987 / SBIR
Agency Tracking Number:
7090
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Immunomed Corpon
5910-g Breckenridge Parkway Tampa, FL 33610
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1987
Title: ANTIGENICITY OF GONOCOCCAL PILUS OLIGOMERS
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE DEVELOPMENT OF A SAFE AND EFFICACIOUS VACCINE FOR GONORRHEA BASED ON OLIGOMERS FROM PILI IS A MAJOR GOAL OF IMMUNOMED CORPORATION. EARLY ATTEMPTS TO DEVELOP GONORRHEA VACCINES USING INTACT PILI FAILED BECAUSE OF ANTIGENIC DIVERSITY AMONG THE BACTERIAL STRAINS IN THE POPULATION. A PRELIMINARY STUDY OF OLIGOMERS FROM THE TYPE 2 COLONIAL FORM OF NEISSERIA GONORRHOEAE HAS SHOWN THAT THEY WERE BETTER THAN INTACT PILI FOR ELICITING ANTIBODIES THAT CROSS-REACT WITH PILI FROM HETEROLOGOUS STRAINS. THIS RESULT SUGGESTS THAT A VACCINE CONTAINING OLIGOMERS SHOULD PROVIDE BETTER CROSS-PROTECTION THAN ONE CONTAINING INTACT PILI. IN THIS PROPOSAL, ANTIBODIES ELICITED BY OLIGOMERS FROM UP TO 10 STRAINS OF NEISERRIA GONORRHOEAE WILL BE EXAMINED TO (1) CONFIRM THEIR CAPACITY FOR CROSS-REACTIVITY WITH INTACT PILI FROM HETEROLOGOUS STRAINS, AND (2) DETERMINE THEIR CAPACITY FOR PREVENTING BACTERIAL ADHESION TO HUMAN CELLS. IF A SIGNIFICANT ADVANTAGE FOR THE USE OF OLIGOMERS IS INDICATED, A PHASE II APPLICATION WOULD BE MADE FOR THE DEVELOPMENT OF A PROTOTYPE GONORRHEA VACCINE BASED ON THOSE STRAINS YIELDING OLIGOMERS WITH THE GREATEST DEGREE OF CROSS-REACTIVITY.

Principal Investigator:

John c mcmichael phd
8136219447

Business Contact:

Small Business Information at Submission:

Immunomed Corpon
5910-g Breckenridge Parkway Tampa, FL 33610

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No